KalVista Pharmaceuticals, Inc. Annual Depreciation, Depletion and Amortization in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary
KalVista Pharmaceuticals, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from 2013 to 2023.
  • KalVista Pharmaceuticals, Inc. Depreciation, Depletion and Amortization for the quarter ending July 31, 2024 was $224K, a 16.1% increase year-over-year.
  • KalVista Pharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2023 was $816K, a 13.6% increase from 2022.
  • KalVista Pharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2022 was $718K, a 27.3% increase from 2021.
  • KalVista Pharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2021 was $564K, a 5.03% increase from 2020.
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $816K +$98K +13.6% May 1, 2023 Apr 30, 2024 10-K 2024-07-11
2022 $718K +$154K +27.3% May 1, 2022 Apr 30, 2023 10-K 2024-07-11
2021 $564K +$27K +5.03% May 1, 2021 Apr 30, 2022 10-K 2024-07-11
2020 $537K +$25K +4.88% May 1, 2020 Apr 30, 2021 10-K 2023-07-10
2019 $512K +$134K +35.5% May 1, 2019 Apr 30, 2020 10-K 2022-07-07
2018 $378K +$198K +110% May 1, 2018 Apr 30, 2019 10-K 2021-07-13
2017 $180K +$140K +350% May 1, 2017 Apr 30, 2018 10-K 2020-07-01
2016 $40K -$93K -69.9% May 1, 2016 Apr 30, 2017 10-K 2019-07-16
2015 $133K +$79K +146% Jan 1, 2015 Dec 31, 2015 10-K 2016-03-30
2014 $54K +$27K +100% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-30
2013 $27K Jan 1, 2013 Dec 31, 2013 10-K 2016-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.